DP
AYTU icon

Diadema Partners’s AYTU BioPharma AYTU Stock Holding History

Diadema Partners’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$319K Sell
148,546
-204,531
-58% -$483K 0.04% 124
2026
Q1 		$964K Buy
353,077
+47,289
+15% +$121K 0.16% 86
2025
Q4 		$795K Buy
305,788
+33,118
+12% +$74.3K 0.14% 99
2025
Q3 		$513K Buy
+272,670
New +$630K 0.13% 98

Other funds holding AYTU

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Crown Advisors Management Larkspur, California $182M AUM 103.97% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Diadema Partners's AYTU Position: Q2 2026 in Review

Diadema Partners reduced its AYTU BioPharma (AYTU) stake by 58% in Q2 2026, selling an estimated $483K and leaving 148,546 shares worth $319K. The position accounts for 0.04% of the portfolio, ranked #124.

Diadema Partners first reported a position in AYTU in Q3 2025 and has held it in 4 quarters since. The position peaked at $964K in Q1 2026. 38 funds tracked by Wall St. Rank hold AYTU as of Q2 2026.

  • Diadema Partners held 148,546 shares of AYTU BioPharma worth $319K as of Q2 2026.
  • Diadema Partners sold 204,531 AYTU BioPharma shares in Q2 2026, an estimated $483K.
  • AYTU BioPharma made up 0.04% of Diadema Partners's portfolio in Q2 2026, its #124 holding.
  • Diadema Partners first reported a position in AYTU BioPharma in Q3 2025 and has held it in 4 quarters since.
  • Diadema Partners's AYTU BioPharma position peaked at $964K in Q1 2026.
  • 38 funds tracked by Wall St. Rank held AYTU BioPharma as of Q2 2026.

Based on Diadema Partners's 13F filing for Q2 2026, filed 14 Aug 2026.